With several systems and process improvement initiatives underway, the growing contract research organization (CRO), Venn Life Sciences, continues to look for earnings enhancing opportunities, says CEO.
The 315 square meter facility will house more than 30 employees in Warsaw, Poland, where the company contract research organization (CRO) has operated since 2008.
Currently, the top ten CROs represent more than half the market, and as the industry continues to grow analysts suggest companies expand revenue streams through “nontraditional” services offerings.
The strategic alliance between Quintiles and the contract research organization (CRO) DaVita Clinical Research will focus on optimizing renal clinical trials.
The independent lab network has combined 11 of its brands, including ABC Laboratories, to reside under a single company in order to “leverage cross functional capabilities,” says CEO.
After much speculation, Pfizer has confirmed it will renew its service agreements with its largest contract research organization customers – as analysts suspected.
ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.
This month marks the renewal period for Pfizer’s contract research organizations’ Icon and Parexel, and while revenues have been declining, analysts believe the pharma giant will renew with both companies.
BioPharmaSpec has set up business development teams for the Indian and Asia-Pacific markets and predicted increased demand for biosimilar characterisation services.
Synexus has bought trial site network Research Across America (RAA) in a deal it claims will give its customers access to the US market and additional study participants.
Anapath has seen a surge in histotechnology services from Europe pharma and rival CROs as consolidation in the preclinical sector has left a lack of capacity for such work.
PRA Health Sciences will launch a recruitment and education drive for trials in the UK this spring in collaboration with advertising agency DJM Pan Unlimited.
Reliance on third-party software vendors differentiates INC Research from its technology-investing peers but will not be a disadvantage, according to a Jefferies analyst.
Growth-hungry CROs will buy trial sites according to David Blume from Edgemont Capital Partners, who told us Icon's acquisition of PMG Research is part of an emerging trend.
Salary increases will only help CROs hold on to staff for so long according to the author of a wages study who says retention is ultimately about building loyalty.
Should small pharma firms stick to small CROs? Quintiles and Covance both believe they can offer the personal touch, but Outsourcing-Pharma wants to know what you think?
Charles River has reported strong Q3 sales despite weakness in Japan and plans to grab space in emerging early discovery, bio-testing and Chinese markets.
The fight between CROs for clinical research associates (CRAs) and people with certain other skillsets is hotting up, with both Icon and Quintiles identifying it as an issue faced by their businesses.
Mid-size CROs (contract research organizations) are banding together once again, this time with Chiltern on Thursday signing a purchase agreement to acquire Theorem Clinical Research.
Mereo BioPharma Group, a recently-formed specialty biopharma company, has selected CRO (contract research organization) Icon as its sole provider of clinical development services.
Australia’s National Health and Medical Research Council (NHMRC) is getting pragmatic with increasingly long clinical trial timelines and is now looking to streamline the research governance process in order to reduce delays in trial commencement.
CRO (contract research organization) PRA Health Sciences reported in its earnings call on Tuesday that earlier in Q2 it acquired Value Health Solutions (VHS), a clinical development software company, for $2.5m.
CRO (contract research organization) Icon reported its highest level of quarterly bookings ever on Tuesday and the company’s stock jumped by about 15%.